7*24 Hotline：
Comfy Pharmaceutical Co., Ltd. (600518)
Kangmei Pharmaceutical Co., Ltd. (600518) was established in 1997 and listed on the Shanghai Stock Exchange in 2001. Adhering to the core values of "cherishing the common people and boundless love" and the business philosophy of "moving the world with love and managing health with heart", the company takes the lead in the layout of the whole industry chain of traditional Chinese medicine under the guidance of the national strategy of revitalizing the cause of traditional Chinese medicine. With traditional Chinese medicine decoction pieces as the core and smart pharmacy as the starting point, it comprehensively builds a "big health + big platform + big data + big service" system, It has become a listed enterprise in the "wisdom +" big health industry with accurate service in the whole industry chain of traditional Chinese medicine.
Kangmei pharmaceutical, from the cultivation and trading of medicinal materials to the production and development and terminal sales, has basically run through the upstream, middle and downstream industries of the traditional Chinese medicine industry chain. Its business penetrates all key links of the whole industry chain of traditional Chinese medicine and effectively integrates the resources of the whole industry chain. The company has invested and established more than 140 enterprises in various parts of the country, covering the cultivation of medicinal materials, trading market of Chinese medicinal materials, modern logistics center and industrial base. The trading scale of the trading market managed by the company accounts for more than 60% of the whole country. The company has taken the lead in making national standards in many aspects, including the formulation of national standards for Chinese herbal pieces, GMP for production management, small packaging, color code management, etc Processing and other national standards; Participate in the formulation of classification standards for Chinese herbal medicines by the Ministry of Commerce of the people's Republic of China; To prepare and operate the only price index of Chinese medicinal materials approved and authorized by the national development and Reform Commission - Kangmei China price index of Chinese medicinal materials; Launch a "combination of entity and virtual market" bulk spot trading platform for Chinese herbal medicine to create a new mode of Chinese herbal medicine trading; Responsible for the preparation of more than 700 national standards for TCM coding, and assisting in the implementation of a unified coding system for TCM, TCM prescriptions and TCM supply chain; As the only pilot unit of the national information medical institution service platform, Kangmei smart pharmacy has been listed as the national research base of traditional Chinese medicine service standardization, creating a new mode of medical treatment and medication in the Internet era; It is an enterprise undertaking the project of processing standard of Chinese herbal pieces of animal medicine in Pharmacopoeia society, and has been approved as a national private network hospital. An expert committee composed of six academicians of Chinese Academy of Sciences, Chinese Academy of engineering and many masters of traditional Chinese medicine has been established. Kangmei Pharmaceutical Research Institute has been established in Guangzhou and Beijing. It has more than 20 national, provincial and ministerial R & D platforms such as "national enterprise technology center". It has carried out nearly 100 national, provincial and ministerial major projects such as internationalization and standardization of traditional Chinese medicine, and presided over and participated in the formulation of national, provincial and ministerial R & D platforms There are dozens of industry standards, 3 laboratories certified by the state or international organizations, 15 science and technology awards at or above the provincial level, and more than 620 intellectual property rights such as invention patents, utility model patents, design patents, and software copyrights. It is a national technology innovation demonstration enterprise, a national intelligent manufacturing pilot demonstration enterprise, and a national intellectual property advantage enterprise.
The company has established 17 modern production bases of Chinese herbal pieces and medicine in China, and established long-term cooperative relations with more than 2000 medical institutions and 200000 pharmacies. The annual total number of outpatient visits has reached more than 250 million person times. It has invested and managed many public hospitals, such as Kangmei hospital, Kangmei Meihekou Central Hospital and Kangmei Kaiyuan central hospital, In more than 100 public hospitals to carry out medical logistics extended distribution services.
Taking the opportunity of the pilot unit of information medical service platform of the State Administration of traditional Chinese medicine, the company takes the lead in the deep layout of the Internet in the whole industry chain of traditional Chinese medicine industry, with traditional Chinese medicine decoction pieces as the core, smart pharmacy as the starting point, around the "big health + big platform + big data + big service" system, and with the resource advantages of the whole industry chain, it actively explores the intelligent manufacturing 4.0 of traditional Chinese medicine industry, Taking the lead in building a "smart pharmacy" model, the general office of the State Council, the National Health Commission, and the State Administration of traditional Chinese medicine have successively issued documents, making it clear that "medical institutions with conditions are encouraged to promote the construction of" smart pharmacy "and realize the seamless connection between prescription system and pharmacy prescription system."“ The mode of "smart pharmacy" has risen to the industry standard, providing "one-stop" pharmaceutical service for patients, realizing "more information and less errands for the masses".
The company continues to carry out targeted poverty alleviation in industry, actively undertakes social responsibility, is enthusiastic about public welfare, cares for charity, helps the poor, helps the disabled and students, builds bridges and roads, etc., drives 2 million pharmaceutical farmers, including 300000 poor farmers, to get rid of poverty and become rich, and continuously provides medicines in short supply for cooperative medical institutions all over the country. In 2015, it handed over the donated Lianhuashan park to the government, In 2018, he took the lead in setting up Puning lianjiang mother river protection foundation, initiated the establishment of Jieyang university student foundation, helped nearly 5000 poor excellent college students complete their studies, and built "Qinghe action" to provide health protection for tens of thousands of orphaned and poor children nationwide, and won the Chinese Charity Award.
Kangmei Pharmaceutical Co., Ltd. will focus on the core business and improve the core competitiveness with the guiding ideology of "limited operation and highlighting the main business". It will clearly take Chinese herbal pieces and their products as the core business. Through the organic integration of the company's industrial layout advantages, online and offline purchasing advantages, R & D and quality control advantages, and marketing service advantages, Kangmei Pharmaceutical Co., Ltd, To become a benchmark enterprise with the ability of dynamic integration and standardized operation of the whole industry chain of traditional Chinese medicine.
oil wellhead